A Study of the Safety, Tolerability and Preliminary Efficacy of DRM01B Topical Gel in Healthy Volunteers and Subjects With Acne Vulgaris
Phase of Trial: Phase I/II
Latest Information Update: 29 May 2019
Price : $35 *
At a glance
- Drugs Olumacostat glasaretil (Primary)
- Indications Acne vulgaris
- Focus Proof of concept; Therapeutic Use
- Sponsors Dermira
- 07 Oct 2015 Results of this trial were presented at the European Academy of Dermatology and Venereology (EADV) Congress, according to a Dermira media release.
- 07 Oct 2015 Results published in a Dermira media release.
- 29 Sep 2015 According to a Dermira media release, new data from this trial will be presented at the European Academy of Dermatology and Venereology (EADV) Congress 2015.